Thorax · 2004 · 363 citations · 16 references
Public HealthImmunologyInfectious DiseasesClinical ImmunologyImmunology Of Infectious DiseasesTuberculosis ControlAntiretroviral TherapyTuberculosis CareTuberculosis EpidemiologyEarly Antiretroviral TherapyHighly Active Antiretroviral TherapyHiv Antiretroviral TherapyHiv-associated ImmunosuppressionHiv-tuberculosis Treatment Co-managementHuman Immunodeficiency Virus-associated TuberculosisParadoxical ReactionsTuberculosis In Immunocompromised Hosts
BACKGROUND: It has been suggested that deterioration of tuberculosis (TB) during appropriate treatment, termed a paradoxical reaction (PR), is more common and severe in HIV positive individuals on highly active antiretroviral therapy (HAART). METHOD: A study was undertaken to determine the frequency of PR and its associated features in a population of HIV+TB+ patients and a similar sized group of HIV-TB+ individuals. RESULTS: PR occurred in 28% of 50 HIV+TB+ patients and 10% of 50 HIV-TB+ patients. Disseminated TB was present in eight of 13 HIV+TB+ patients and four of five HIV-TB+ patients with PR. In 28 HIV+TB+ patients starting HAART, PR was significantly associated with commencing HAART within 6 weeks of starting antituberculosis treatment (p = 0.03) and was more common in those with disseminated TB (p = 0.09). No association was found between development of PR and baseline CD4 count or CD4 response to HAART. CONCLUSIONS: PR is common in HIV infected and uninfected individuals with TB. Early introduction of HAART and the presence of disseminated TB appear to be important in co-infected patients.
16
Impact of HIV on tuberculosis in Zambia: a cross sectional study.
Alison M. Elliott, N. Luo, Godwin Tembo et al. · BMJ · 1990 · 237 citations · Full text